Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IL › Aurora › NPI 1558886861
NP / PA

Sexton, Michelle

Sexton, Michelle was paid $736K by Medicaid between Jan 2018 and Apr 2023, across 9 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 74% of everything it billed.

33Billing provider infoSEXTON, MICHELLE
AURORA, IL 60506
33aNPI1558886861assigned 08/08/2017
28Total paid$736K
24GClaims17,103
24DCodes billed9
24AFirst – last monthJan 2018 – Apr 2023
Compared with peers

Next to other Family Nurse Practitioner providers in Illinois

Rank by total paid#27 of 3,353
Median peer was paid$25K
This provider vs. median30×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201841$0.00
20219,971$491K
20226,862$240K
2023229$5K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 74% 7,234 6,236 $541K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 10% 3,180 3,019 $75K
99000 7.8% 2,448 2,353 $57K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 7.8% 2,310 2,244 $57K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 1,561 1,108 $6K
1170F 0% 14 14 $0.00
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 0% 17 15 $0.00
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 0% 315 302 $0.00
T1015 A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive 0% 24 23 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.